Transcatheter Aortic Valve Replacement (TAVR)-Pilot Trial (TAVR-PT)

January 27, 2017 updated by: NYU Langone Health

Intensive Versus Usual Home-based Physical Therapy to Promote Functional Recovery After Transcatheter Aortic Valve Replacement (TAVR): A Pilot Randomized Trial

The primary purpose of this this randomized interventional study is to determine if increased level of home-based rehabilitation coupled with a pre-TAVR consultation visit in transcatheter aortic valve replacement patients will improve functional status and quality of life and will decrease hospital readmission.

Study Overview

Study Type

Interventional

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

75 years and older (Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Diagnosis of severe aortic stenosis (AS) as determined by echocardiography, who are deemed eligible for TAVR by the NYULMC Heart Valve Team

Exclusion Criteria:

  • Decisional impairment as assessed by the University of California, San Diego Brief Assessment of Capacity to Consent (UBACC)
  • Non-English/non-Spanish speaking.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Prehabilitation Visit/Increased Physical Therapy post-TAVR
Prior to TAVR, patients randomized to the intervention arm will meet with a licensed physical therapist for a 30-minute session in the ambulatory setting. Following TAVR, patients randomized to the intervention arm will receive 4 days per week of home-based physical therapy by a licensed physical therapist working for Revival Home Health Care
Active Comparator: Control
Standard of care physical therapy post-TAVR
Patients randomized to the usual care arm will receive home-based physical therapy for 2 days per week by Revival Home Health Care, which is the current standard of care.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Change in level of Activity measured by activity monitor called the ActiGraph wGT3X-BT.
Time Frame: Baseline, 2 Weeks
Baseline, 2 Weeks
Change in self-perceived physical health
Time Frame: Baseline, 2 Weeks
Baseline, 2 Weeks
Change in Independence in activities of daily living (ADLs).
Time Frame: Baseline, 2 Weeks
Baseline, 2 Weeks

Secondary Outcome Measures

Outcome Measure
Time Frame
Reduction in hospital readmissions following intensive home-based physical therapy reduces
Time Frame: Baseline, 2 Weeks
Baseline, 2 Weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: John Dodson, MD, New York University Medical School

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

January 1, 2017

Primary Completion (Actual)

January 1, 2017

Study Completion (Actual)

January 1, 2017

Study Registration Dates

First Submitted

March 9, 2016

First Submitted That Met QC Criteria

March 23, 2016

First Posted (Estimate)

March 30, 2016

Study Record Updates

Last Update Posted (Estimate)

January 30, 2017

Last Update Submitted That Met QC Criteria

January 27, 2017

Last Verified

January 1, 2017

More Information

Terms related to this study

Other Study ID Numbers

  • 15-01098

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Transcatheter Aortic Valve Replacement (TAVR)

Clinical Trials on Prehabilitation visit/increased physical therapy post-TAVR

3
Subscribe